Publications
- Experience with ruxolitinib in the treatment of myelofibrosis and polycythaemia vera at Czech haematological institutions2017 | Faculty of Medicine in Hradec Králové
- Long-term treatment results of chronic myelomonocytic leukaemia in selected haematological centres2017 | Faculty of Medicine in Hradec Králové
- Improvement of Anaemia in Patients with Primary Myelofibrosis by Low-Dose Thalidomide and Prednisone2016 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- Lenalidomide treatment in myelodysplastic syndrome with 5q deletion - Czech MDS group experience2015 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Second Faculty of Medicine
- Diagnostics and treatment of chronic myelomonocytic leukemia in the years 2000-2013 - results from 2 hematologic centres2014 | Faculty of Medicine in Hradec Králové
- Thrombocytopenia at diagnosis as an important negative prognostic marker in isolated 5q-MDS (IPSS low and intermediate-1)2012 | Publication without faculty affiliation
- Dasatinib as first line therapy in chronic myeloid leukaemia2011 | Faculty of Medicine in Hradec Králové
- Therapy-related MDS/AML after autologous stem cell transplantation for lymphoma with BEAM as conditioning: our experience +12008 | Faculty of Medicine in Hradec Králové
- Research Report University Hospital for clinical assessment 20090160Publication without faculty affiliation
- Report of University Hospital Hradec Králové to the clinical trial protocol No: 20090160-21010Publication without faculty affiliation
Loading network view...